Groupe Bruxelles Lambert

Ultime notizie

Titoli nella lingua originale della fonte.

• Novartis wagers almost $8B on a Chinese biotech’s RNA drugs (si apre in una nuova scheda)

  2 ott 2026

• 
  Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal (si apre in una nuova scheda)

  2 ott 2026

• 
  Agios' Growth Story Hinges on Mitapivat's Commercial Expansion (si apre in una nuova scheda)

  2 ott 2026

• 
  Novartis Signs RNA Therapy Licensing Deal With China’s Abogen Worth Up to $7.8 Billion (si apre in una nuova scheda)

  2 ott 2026

• 
  Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs (si apre in una nuova scheda)

  2 ott 2026

• Groupe Bruxelles Lambert : GBL – Stemrechten en noemer – Situatie op 30 september 2026 (si apre in una nuova scheda)

  MarketScreener Nederland · 1 ott 2026

• Change in the holding of Suominen’s treasury shares (si apre in una nuova scheda)

  1 ott 2026

• Deutsche Bank lists Top European Stock picks for the next twelve months (si apre in una nuova scheda)

  1 ott 2026

• Suominen Corporation – Manager’s transaction: Charles Héaulmé (si apre in una nuova scheda)

  1 ott 2026

• Rezolv secures up to $636m for 1.3GWp Dama Solar project in Romania (si apre in una nuova scheda)

  1 ott 2026

• Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth (si apre in una nuova scheda)

  1 ott 2026

• Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson (si apre in una nuova scheda)

  30 set 2026

• CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J (si apre in una nuova scheda)

  30 set 2026

• Schweizer Electronic AG Transitions to the Scale Segment of the Frankfurt Stock Exchange (si apre in una nuova scheda)

  29 set 2026

• CAS announces collaboration with Novartis to advance AI-ready reaction informatics (si apre in una nuova scheda)

  29 set 2026

• Hungary’s OTP Bank weighs Russia exit amid Luminor purchase – report (si apre in una nuova scheda)

  29 set 2026

• Global chip stocks rise as Anthropic spending outlook lifts AI demand hopes (si apre in una nuova scheda)

  29 set 2026

• European equities give up gains despite oil decline and Anthropic’s outlook (si apre in una nuova scheda)

  29 set 2026

• ARTHEx Biotech Announces Appointment of Glenn P. Sblendorio as Chairman of the Board (si apre in una nuova scheda)

  29 set 2026

• 
  Groupe Bruxelles Lambert (ENXTBR:GBLB): Assessing Valuation After Recent Period of Steady Share Price Gains (si apre in una nuova scheda)

  Simply Wall St. · 4 ott 2025